Catecholamine stress echocardiography

Stephen Sawada, D. S. Segar, T. Ryan, A. M. Dohan, R. Williams, Harvey Feigenbaum

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Two-dimensional echocardiographic monitoring during catecholamine infusion has shown promise as a safe and accurate method for detection of coronary artery disease. The clinical application of catecholamine stress echocardiography has been facilitated by the development of digital image processing techniques. The sensitivity of this method of stress testing has been improved by drug infusion protocols that are designed to maximize myocardial stress. Recent investigations have demonstrated the value of dobutamine stress echocardiography for detection of multivessel disease following myocardial infarction and for assessment of cardiac risk before noncardiac surgery. Evaluation of changes in wall motion and thickening that occur during low dose dobutamine infusion may enable detection of viable myocardium after thrombolytic treatment of acute myocardial infarction. Compared to alternative noninvasive diagnostic methods, catecholamine stress echocardiography permits continuous acquisition of high-quality information on regional and global systolic function. This and other advantages have prompted the search for broader applications of this technique.

Original languageEnglish
Pages (from-to)177-188
Number of pages12
JournalEchocardiography
Volume9
Issue number2
StatePublished - 1992

Fingerprint

Stress Echocardiography
Catecholamines
Myocardial Infarction
Dobutamine
Coronary Artery Disease
Myocardium
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Sawada, S., Segar, D. S., Ryan, T., Dohan, A. M., Williams, R., & Feigenbaum, H. (1992). Catecholamine stress echocardiography. Echocardiography, 9(2), 177-188.

Catecholamine stress echocardiography. / Sawada, Stephen; Segar, D. S.; Ryan, T.; Dohan, A. M.; Williams, R.; Feigenbaum, Harvey.

In: Echocardiography, Vol. 9, No. 2, 1992, p. 177-188.

Research output: Contribution to journalArticle

Sawada, S, Segar, DS, Ryan, T, Dohan, AM, Williams, R & Feigenbaum, H 1992, 'Catecholamine stress echocardiography', Echocardiography, vol. 9, no. 2, pp. 177-188.
Sawada S, Segar DS, Ryan T, Dohan AM, Williams R, Feigenbaum H. Catecholamine stress echocardiography. Echocardiography. 1992;9(2):177-188.
Sawada, Stephen ; Segar, D. S. ; Ryan, T. ; Dohan, A. M. ; Williams, R. ; Feigenbaum, Harvey. / Catecholamine stress echocardiography. In: Echocardiography. 1992 ; Vol. 9, No. 2. pp. 177-188.
@article{e862f8fab991468aa9c6b42a501adfe2,
title = "Catecholamine stress echocardiography",
abstract = "Two-dimensional echocardiographic monitoring during catecholamine infusion has shown promise as a safe and accurate method for detection of coronary artery disease. The clinical application of catecholamine stress echocardiography has been facilitated by the development of digital image processing techniques. The sensitivity of this method of stress testing has been improved by drug infusion protocols that are designed to maximize myocardial stress. Recent investigations have demonstrated the value of dobutamine stress echocardiography for detection of multivessel disease following myocardial infarction and for assessment of cardiac risk before noncardiac surgery. Evaluation of changes in wall motion and thickening that occur during low dose dobutamine infusion may enable detection of viable myocardium after thrombolytic treatment of acute myocardial infarction. Compared to alternative noninvasive diagnostic methods, catecholamine stress echocardiography permits continuous acquisition of high-quality information on regional and global systolic function. This and other advantages have prompted the search for broader applications of this technique.",
author = "Stephen Sawada and Segar, {D. S.} and T. Ryan and Dohan, {A. M.} and R. Williams and Harvey Feigenbaum",
year = "1992",
language = "English",
volume = "9",
pages = "177--188",
journal = "Echocardiography",
issn = "0742-2822",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Catecholamine stress echocardiography

AU - Sawada, Stephen

AU - Segar, D. S.

AU - Ryan, T.

AU - Dohan, A. M.

AU - Williams, R.

AU - Feigenbaum, Harvey

PY - 1992

Y1 - 1992

N2 - Two-dimensional echocardiographic monitoring during catecholamine infusion has shown promise as a safe and accurate method for detection of coronary artery disease. The clinical application of catecholamine stress echocardiography has been facilitated by the development of digital image processing techniques. The sensitivity of this method of stress testing has been improved by drug infusion protocols that are designed to maximize myocardial stress. Recent investigations have demonstrated the value of dobutamine stress echocardiography for detection of multivessel disease following myocardial infarction and for assessment of cardiac risk before noncardiac surgery. Evaluation of changes in wall motion and thickening that occur during low dose dobutamine infusion may enable detection of viable myocardium after thrombolytic treatment of acute myocardial infarction. Compared to alternative noninvasive diagnostic methods, catecholamine stress echocardiography permits continuous acquisition of high-quality information on regional and global systolic function. This and other advantages have prompted the search for broader applications of this technique.

AB - Two-dimensional echocardiographic monitoring during catecholamine infusion has shown promise as a safe and accurate method for detection of coronary artery disease. The clinical application of catecholamine stress echocardiography has been facilitated by the development of digital image processing techniques. The sensitivity of this method of stress testing has been improved by drug infusion protocols that are designed to maximize myocardial stress. Recent investigations have demonstrated the value of dobutamine stress echocardiography for detection of multivessel disease following myocardial infarction and for assessment of cardiac risk before noncardiac surgery. Evaluation of changes in wall motion and thickening that occur during low dose dobutamine infusion may enable detection of viable myocardium after thrombolytic treatment of acute myocardial infarction. Compared to alternative noninvasive diagnostic methods, catecholamine stress echocardiography permits continuous acquisition of high-quality information on regional and global systolic function. This and other advantages have prompted the search for broader applications of this technique.

UR - http://www.scopus.com/inward/record.url?scp=0026508021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026508021&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 177

EP - 188

JO - Echocardiography

JF - Echocardiography

SN - 0742-2822

IS - 2

ER -